IDO: A double-edged sword for TH1/TH2 regulation

Immunology Letters

Volumn 121, Issue 1, 2008, Pages 1-6

  Xu, Hui ^a   Zhang, Guang Xian ^a   Ciric, Bogoljub ^a   Rostami, Abdolmohamad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Dendritic cells; Immune diseases; Immune regulation; T cells; Tryptophan

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE;

CELL DIFFERENTIATION; IMMUNE RESPONSE; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TRYPTOPHAN METABOLISM;

ANIMALS; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; KYNURENINE; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTORS; TRYPTOPHAN; UP-REGULATION;

EID: 54049133593     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.08.008     Document Type: Review

References (70)

1. Stone T.W., and Darlington L.G. Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1 (2002) 609-620
2. Mellor A.L., and Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4 (2004) 762-774
3. Beutelspacher S.C., Tan P.H., McClure M.O., Larkin D.F., Lechler R.I., and George A.J. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant 6 (2006) 1320-1330
4. Odemuyiwa S.O., Ghahary A., Li Y., Puttagunta L., Lee J.E., Musat-Marcu S., et al. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol 173 (2004) 5909-5913
5. Munn D.H., and Mellor A.L. IDO and tolerance to tumors. Trends Mol Med 10 (2004) 15-18
6. Uyttenhove C., Pilotte L., Theate I., Stroobant V., Colau D., Parmentier N., et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9 (2003) 1269-1274
7. Agaugue S., Perrin-Cocon L., Coutant F., Andre P., and Lotteau V. 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. J Immunol 177 (2006) 2061-2071
8. Munn D.H. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr Opin Immunol 18 (2006) 220-225
9. Puccetti P., and Fallarino F. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis 40 (2008) 101-105
10. Mellor A.L., and Munn D.H. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol 8 (2008) 74-80
11. Terness P., Kallikourdis M., Betz A.G., Rabinovich G.A., Saito S., and Clark D.A. Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am J Reprod Immunol 58 (2007) 238-254
12. Katz J.B., Muller A.J., and Prendergast G.C. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 222 (2008) 206-221
13. Munn D.H., and Mellor A.L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117 (2007) 1147-1154
14. Puccetti P., and Grohmann U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 7 (2007) 817-823
15. Terness P., Chuang J.J., and Opelz G. The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends Immunol 27 (2006) 68-73
16. Fallarino F., Grohmann U., You S., McGrath B.C., Cavener D.R., Vacca C., et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells. J Immunol 176 (2006) 6752-6761
17. MacKenzie C.R., Heseler K., Muller A., and Daubener W. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr Drug Metab 8 (2007) 237-244
18. Choi B.K., Asai T., Vinay D.S., Kim Y.H., and Kwon B.S. 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms. Cytokine 34 (2006) 233-242
19. Gurtner G.J., Newberry R.D., Schloemann S.R., McDonald K.G., and Stenson W.F. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125 (2003) 1762-1773
20. Platten M., Ho P.P., Youssef S., Fontoura P., Garren H., Hur E.M., et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310 (2005) 850-855
21. Orabona C., Puccetti P., Vacca C., Bicciato S., Luchini A., Fallarino F., et al. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 107 (2006) 2846-2854
22. Orabona C., Tomasello E., Fallarino F., Bianchi R., Volpi C., Bellocchio S., et al. Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. Eur J Immunol 35 (2005) 3111-3118
23. Kwidzinski E., Bunse J., Aktas O., Richter D., Mutlu L., Zipp F., et al. Indoleamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J 19 (2005) 1347-1349
24. Grohmann U., Fallarino F., Bianchi R., Orabona C., Vacca C., Fioretti M.C., et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 198 (2003) 153-160
25. Saxena V., Ondr J.K., Magnusen A.F., Munn D.H., and Katz J.D. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J Immunol 179 (2007) 5041-5053
26. Ueno A., Cho S., Cheng L., Wang J., Hou S., Nakano H., et al. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. Diabetes 56 (2007) 1686-1693
27. Romani L., Fallarino F., De Luca A., Montagnoli C., D'Angelo C., Zelante T., et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451 (2008) 211-215
28. Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A., et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 9 (2002) 1069-1077
29. Clark D.A., Blois S., Kandil J., Handjiski B., Manuel J., and Arck P.C. Reduced uterine indoleamine 2,3-dioxygenase versus increased Th1/Th2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. Am J Reprod Immunol 54 (2005) 203-216
30. Molano A., Illarionov P.A., Besra G.S., Putterman C., and Porcelli S.A. Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase. Immunol Lett 117 (2008) 81-90
31. Xu H., Oriss T.B., Fei M., Henry A.C., Melgert B.N., Chen L., et al. Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci USA 105 (2008) 6690-6695
32. Chen X., Liu L., Yang P., Wu C., Jin H., Xing L., et al. Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation. Immunol Lett 107 (2006) 140-147
33. Hayashi T., Beck L., Rossetto C., Gong X., Takikawa O., Takabayashi K., et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 114 (2004) 270-279
34. Ishii K.J., and Akira S. Innate immune recognition of, and regulation by DNA. Trends Immunol 27 (2006) 525-532
35. Kline J.N. Effects of CpG DNA on Th1/Th2 balance in asthma. Curr Top Microbiol Immunol 247 (2000) 211-225
36. -, dendritic cells tolerize Th2 responses via contact-dependent and -independent mechanisms, and reverse airway hyperresponsiveness, Th2, and eosinophil responses in a mouse model of asthma. J Immunol 175 (2005) 1516-1522
37. Colonna M., Trinchieri G., and Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat Immunol 5 (2004) 1219-1226
38. Puccetti P. On watching the watchers: IDO and type I/II IFN. Eur J Immunol 37 (2007) 876-879
39. Adams O., Besken K., Oberdorfer C., MacKenzie C.R., Takikawa O., and Daubener W. Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J Virol 78 (2004) 2632-2636
40. Taylor M.W., and Feng G.S. Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5 (1991) 2516-2522
41. Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4 (2003) 1206-1212
42. Suzue K., Asai T., Takeuchi T., and Koyasu S. In vivo role of IFN-γ produced by antigen-presenting cells in early host defense against intracellular pathogens. Eur J Immunol 33 (2003) 2666-2675
43. Fricke I., Mitchell D., Mittelstadt J., Lehan N., Heine H., Goldmann T., et al. Mycobacteria induce IFN-γ production in human dendritic cells via triggering of TLR2. J Immunol 176 (2006) 5173-5182
44. Fujii S., Liu K., Smith C., Bonito A.J., and Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199 (2004) 1607-1618
45. Stober D., Schirmbeck R., and Reimann J. IL-12/IL-18-dependent IFN-γ release by murine dendritic cells. J Immunol 167 (2001) 957-965
46. Trinchieri G. Immunobiology of interleukin-12. Immunol Res 17 (1998) 269-278
47. Berenson L.S., Ota N., and Murphy K.M. Issues in T-helper 1 development-resolved and unresolved. Immunol Rev 202 (2004) 157-174
48. + T regulatory cells. Blood 109 (2007) 2871-2877
49. high regulatory T cells by promoting maturation of LPS-treated dendritic cells. Eur J Immunol 37 (2007) 3054-3062
50. Sharma M.D., Baban B., Chandler P., Hou D.Y., Singh N., Yagita H., et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 117 (2007) 2570-2582
51. Munn D.H., Sharma M.D., Baban B., Harding H.P., Zhang Y., Ron D., et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22 (2005) 633-642
52. Derks R.A., Jankowska-Gan E., Xu Q., and Burlingham W.J. Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1. J Immunol 179 (2007) 3443-3451
53. Quah B.J., and O'Neill H.C. Maturation of function in dendritic cells for tolerance and immunity. J Cell Mol Med 9 (2005) 643-654
54. Hwang S.L., Chung N.P., Chan J.K., and Lin C.L. Indoleamine 2,3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. Cell Res 15 (2005) 167-175
55. Mellor A.L., Baban B., Chandler P., Marshall B., Jhaver K., Hansen A., et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 171 (2003) 1652-1655
56. Grohmann U., Bianchi R., Orabona C., Fallarino F., Vacca C., Micheletti A., et al. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J Immunol 171 (2003) 2581-2587
57. Belladonna M.L., Grohmann U., Guidetti P., Volpi C., Bianchi R., Fioretti M.C., et al. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J Immunol 177 (2006) 130-137
58. Hayashi T., Mo J.H., Gong X., Rossetto C., Jang A., Beck L., et al. 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci USA 104 (2007) 18619-18624
59. Sakurai K., Zou J.P., Tschetter J.R., Ward J.M., and Shearer G.M. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 129 (2002) 186-196
60. Alexander A.M., Crawford M., Bertera S., Rudert W.A., Takikawa O., Robbins P.D., et al. Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 51 (2002) 356-365
61. Funeshima N., Fujino M., Kitazawa Y., Hara Y., Hara Y., Hayakawa K., et al. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase. J Gene Med 7 (2005) 565-575
62. + cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 30 (2004) 311-318
63. Mellor A.L., Keskin D.B., Johnson T., Chandler P., and Munn D.H. Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol 168 (2002) 3771-3776
64. von Bergwelt-Baildon M.S., Popov A., Saric T., Chemnitz J., Classen S., Stoffel M.S., et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 108 (2006) 228-237
65. Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., and Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196 (2002) 459-468
66. van der Marel A.P., Samsom J.N., Greuter M., van Berkel L.A., O'Toole T., Kraal G., et al. Blockade of IDO inhibits nasal tolerance induction. J Immunol 179 (2007) 894-900
67. Jasperson L.K., Bucher C., Panoskaltsis-Mortari A., Taylor P.A., Mellor A.L., Munn D.H., et al. Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality. Blood 111 (2008) 3257-3265
68. Reddy P., Sun Y., Toubai T., Duran-Struuck R., Clouthier S.G., Weisiger E., et al. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest 118 (2008) 2562-2573
69. Montagnoli C., Fallarino F., Gaziano R., Bozza S., Bellocchio S., Zelante T., et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 176 (2006) 1712-1723
70. Grohmann U., Volpi C., Fallarino F., Bozza S., Bianchi R., Vacca C., et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13 (2007) 579-586